Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estriol for Urogenital Health and Remyelination in RRMS
NCT03774407Phase 3Completed
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Jun 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of estriol in multiple sclerosis (MS), neurogenic bladder, sponsored by Texas Tech University Health Sciences Center. Started Jun 2019; status: completed.
02
Drugs
estriol
03
Conditions
multiple sclerosis (MS)neurogenic bladder
Beyond the preview
Go deeper on NCT03774407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774407.